• Skip to main content
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Research and Innovation: Institutional Review Board
  • UAMS Health
  • Jobs
  • Giving
  • About
    • Compliance Statement
    • Full Board Meetings
      • Committee Rosters
    • Institutional Review Board Blogs
    • Institutional Review Board Staff
    • Join the UAMS Institutional Review Board
    • Review Fees
  • CLARA
    • Access the System
    • Request a Human Subjects Research Determination
    • Start a Study
  • Templates, Training and Tools
    • Consent for Non-English Speakers
    • Events and Deviations Tables
    • Expanded Access Programs: Compassionate Use & Emergency Use
    • Human Subject Protection Training Instructions
  • Reporting to the Institutional Review Board
  • Expanded Access
  • Institutional Review Board Policies
    • Current Institutional Review Board Policies
      • 1 Principles and Authority
      • 2 Relationships
      • 3 Committee Membership
      • 4 Institutional Review Board Operations
      • 5 Records (Retired)
      • 6 Documentation
      • 7 Procedures for Study Review
      • 8 Change in Protocol
      • 9 Institutional Review Board Decisions
      • 10 Principal Investigator Responsibilities
      • 11 Appeals and Reconsiderations (retired)
      • 12 Quality Assurances
      • 13 Confidentiality
      • 14 Recruitment Practices
      • 15 Consent
      • 16 Risk / Benefit Analysis (moved)
      • 17 Special Populations
      • 18 Drugs and Devices
      • 19 Human Genetics Guidance
      • 20 Questions, Concerns, Suggestions and Complaints
    • Institutional Review Board Policy Archives
      • 1 Principles and Authority Archive
      • 2 Relationships Archive
      • 3 Committee Membership Archive
      • 4 Institutional Review Board Operations Archive
      • 5 Records Archive
      • 6 Documentation Archive
      • 7 Procedures for Study Review Archive
      • 8 Change in Protocol Archive
      • 9 Institutional Review Board Decisions Archive
      • 10 Principal Investigator Responsibilities Archive
      • 11 Appeals and Reconsiderations Archive
      • 12 Quality Assurances Archive
      • 13 Confidentiality Archive
      • 14 Recruitment Practices Archive
      • 15 Consent Archive
      • 16 Risk / Benefit Analysis Archive
      • 17 Special Populations Archive
      • 18 Drugs and Devices Archive
      • 19 Human Genetics Guidance Archive
      • 20 Questions, Concerns, Suggestions, Complaints Archive
  • Research Resources
    • Acronyms and Resources
    • FAQs
      • CITI Program FAQs
      • CLARA FAQs
      • Does my project need IRB review?
      • Prereview and Review Process FAQs
      • Reporting FAQs
      • Submission FAQs
    • Single / Central Institutional Review Board Review
  • Human Research Protection Program Plan
  1. University of Arkansas for Medical Sciences
  2. Research and Innovation
  3. Institutional Review Board
  4. Research Resources
  5. Acronyms and Resources

Acronyms and Resources

A

  • AAHRPP: Association for the Accreditation of Human Research Protection Programs — Accredits the UAMS human research protection program.
  • ACH: Arkansas Children’s Hospital
  • ACRI: Arkansas Children’s Research Institute
  • ACNC: Arkansas Children’s Nutrition Center
  • AE: adverse event

C

  • CTO: Clinical Trials Office at the Winthrop P. Rockefeller Cancer Institute
  • CFR: Code of Federal Regulations.
  • Children in Research
  • CIRB: Central Institutional Review Board (National Cancer Institute)
  • CITI: Collaborative Institutional Training Initiative — site for the required human subject protection training
  • CLARA: Clinical Research Administration system
  • ClinicalTrials.gov
  • COG: Children’s Oncology Group
  • COI: conflict of interest
  • Common Rule — Regulations governing federally funded research
  • Compliance Statement
  • CR: continuing review
  • Criteria for Approval

D

  • DCFS: Division of Children and Family Services (Arkansas Division of Human Services) Mentioned in IRB Policy 17.1.
  • Disease Oriented Committee
  • DOJ: Department of Justice
  • DSM: Data and Safety Monitor; data and safety monitoring
  • DSMB: Data and Safety Monitoring Board
  • DSMC: Data and Safety Monitoring Committee
  • DSMP: Data and Safety Monitoring Plan
  • DUA: data use agreement

E

  • ePHI: Electronic Protected Health Information
  • Exception from Informed Consent (EFIC) research Also known as “planned emergency research”

F

  • FDA regulations — Govern research involving FDA-regulated products. 21 CFR 50 addresses human subject protections. 21 CFR 56 addresses IRB functions.
  • FERPA: Family Educational Rights and Privacy Act
  • FWA: Federalwide Assurance

G

  • GOG: Gynecologic Oncology Group

H

  • HDE: Humanitarian Device Exemption. See questions 7-10 in this guidance for information about the IRB’s role in HUD use.
  • HIPAA: Health Insurance Portability and Accountability Act
  • HITECH: Health Information Technology for Economic and Clinical Health Act
  • HRPP: Human Research Protection Program
  • HUD: Humanitarian Use Device. See HDE above for references.

I

  • Informed Consent
  • ICMJE: International Committee of Medical Journal Editors
  • IDE: Investigational Device Exemption
  • IND: Investigational New Drug
  • IRB: Institutional Review Board

L

  • LAR: legally authorized representative (in a consent form)
  • LDS: limited data set

M

  • Minimal Risk

N

  • NCT: National Clinical Trials (number) — a unique identifier given to a clinical study on ClinicalTrials.gov (National Institutes of Health)
  • NDA: non-disclosure agreement
  • NICE: New Investigation Consult and Education (Office of Research Compliance review of investigator-initiated studies following Institutional Review Board approval)
  • Noncompliance (minor, serious, continuing)
  • NSR: Non-significant Risk (pertains to an investigational device only)

O

  • OHRP: Office for Human Research Protections (U.S. Department of Health and Human Services)
  • ORC: Office of Research Compliance
  • ORSP: Office of Research and Sponsored Programs

P

  • PCRU: Pediatric Clinical Research Unit (Arkansas Children’s)
  • PHI: Protected Health Information
  • PI: principal investigator
  • POG: Pediatric Oncology Group
  • Planned Emergency Research Also known as EFIC research
  • PPRU: Pediatric Pharmacology Research Unit (Arkansas Children’s)
  • PRI: UAMS Psychiatric Research Institute
  • PRIM&R: Public Responsibility in Medicine and Research
  • Prisoners in Research
  • PRMC: Protocol Review and Monitoring Committee

R

  • Reportable New Event
  • Reviewer Checklists

S

  • Significant Risk (pertains to investigational devices only)
  • SOP: Standard Operating Procedure
  • SWOG: Southwest Oncology Group

T

  • TRI: UAMS Translational Research Institute

U

  • UPIRTSO: unanticipated problems involving risks to subjects and others

University of Arkansas for Medical Sciences LogoUniversity of Arkansas for Medical SciencesUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • X
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement
  • Legal Notices

© 2026 University of Arkansas for Medical Sciences